Positive
clinical results propelled a small biopharma stock Monday, while some
shareholders were less than thrilled with a higher purchase price. Here’s some
small stocks making big moves on Monday, September 28, 2015 (as of 4 pm EST):
Aeterna Zentaris Inc. (TSX: AEZ) shares gained 17% to $0.14 on volume of more
than 4 million shares Monday after the specialty biopharmaceutical company announced
that its lead oncology compound, zoptarelin doxorubicin (formerly AEZS?108),
met the primary end-point of the investigator-driven and sponsored Phase 2
clinical trial in Castration and taxane Resistant Prostate Cancer and
demonstrated good tolerability.
As well,
shares of Imperus Technologies Corp.
(TSXV:
LAB) slid 29% to $0.125 as the developer of social and mobile gaming
said it has entered into an amendment to the option agreement to acquire all of
the issued and outstanding shares of the social gaming company Akamon
Entertainment Millennium, S.L., in which the purchase price will be increased
by US$350,000.
Ballard Power Systems (TSX:
BLD), meanwhile, reported that it has signed a joint development and supply
agreement to develop and commercialize a fuel cell engine specifically designed
for integration into low floor trams manufactured by CRRC Qingdao Sifang
Company, Ltd., a Chinese rolling stock manufacturer. The initial value expected
to be approximately $6 million. Ballard Power stock moved up 7% to $1.63
following the announcement.
Hi, did you know SmallCapPower
accepts blog submissions? You can contact me at sean@smallcappower.com.
